IMPEDIMED LIMITED — Director's Dealing 2021

Apr 6, 2021

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity: ImpediMed Limited ABN: 089 705 144

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Judith Downes
Date of last notice	06 January 2021

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

	Direct or indirect interest		Direct and Indirect
				rannuationber of NPation Fund
	Nature of indirect interest(including registered holder)Note: Provide details of the	circumstances	NP Downes Pty Ltd Staff SupeFund
	giving rise to the relevant inter	est.	Ms Downes is director and meDownes Pty Ltd Staff Superannuand a beneficiary of the fund.
	Date of change		01 April 2021
	No. of securities held prior to	change	Direct:
	Class		Ordinary shares

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Number acquired	Direct:
	170,455 Ordinary Shares
Number disposed	Nil
Value/Consideration	$0.11 per share
Note: If consideration is non-cash, provide
details and estimated valuation
No. of securities held after change	Direct:
	1,558,237 Ordinary shares
	299,648 Options
	Indirect:
	253,309 Ordinary shares
	143,175 Options
Nature of change	Issue of shares in lieu of director fees for
Example: on-market trade, off-market trade,	quarter ended 31 March 2021.
exercise of options, issue of securities under
dividend reinvestment plan, participation in
buy-back

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

• See chapter 19 for defined terms.

Appendix 3Y Page 2

Appendix 3Y Change of Director’s Interest Notice

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required?	No
If so, was prior written clearance provided to allow thetrade to proceed during this period?
If prior written clearance was provided, on what date wasthis provided?

Date of Notice: 07 April 2021

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3